Ion Beam Applications SA (IBAB) - Total Assets

Latest as of June 2025: €626.99 Million EUR ≈ $733.02 Million USD

Based on the latest financial reports, Ion Beam Applications SA (IBAB) holds total assets worth €626.99 Million EUR (≈ $733.02 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Ion Beam Applications SA total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Ion Beam Applications SA - Total Assets Trend (2000–2024)

This chart illustrates how Ion Beam Applications SA's total assets have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Ion Beam Applications SA to see how much of total assets are deployed in long-term investments.

Ion Beam Applications SA - Asset Composition Analysis

Current Asset Composition (December 2024)

Ion Beam Applications SA's total assets of €626.99 Million consist of 72.7% current assets and 27.3% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 11.7%
Accounts Receivable €218.10 Million 35.4%
Inventory €152.80 Million 24.8%
Property, Plant & Equipment €0.00 0.0%
Intangible Assets €13.99 Million 2.3%
Goodwill €11.68 Million 1.9%

Asset Composition Trend (2000–2024)

This chart illustrates how Ion Beam Applications SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Ion Beam Applications SA (IBAB) total market value.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Ion Beam Applications SA's current assets represent 72.7% of total assets in 2024, an increase from 0.0% in 2000.
  • Cash Position: Cash and equivalents constituted 11.7% of total assets in 2024, up from 2.4% in 2000.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 60.0% in 2000.
  • Asset Diversification: The largest asset category is accounts receivable at 35.4% of total assets.

Ion Beam Applications SA Competitors by Total Assets

Key competitors of Ion Beam Applications SA based on total assets are shown below.

Company Country Total Assets
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
Germany €2.83 Billion
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
China CN¥16.89 Billion
Novocure Ltd
NASDAQ:NVCR
USA $787.93 Million
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
China CN¥2.00 Billion
Jafron Biomedical Co Ltd
SHE:300529
China CN¥5.52 Billion
Anteris Technologies Global Corp
AU:AVR
Australia AU$19.07 Million
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
China CN¥3.54 Billion
Tellgen Corp
SHE:300642
China CN¥2.01 Billion

Ion Beam Applications SA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.94 0.96 1.28
Quick Ratio 0.62 0.64 0.84
Cash Ratio 0.00 0.00 0.00
Working Capital €-30.30 Million €-17.92 Million €74.12 Million

Ion Beam Applications SA - Advanced Valuation Insights

This section examines the relationship between Ion Beam Applications SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 3.73
Latest Market Cap to Assets Ratio 0.76
Asset Growth Rate (YoY) 3.1%
Total Assets €616.10 Million
Market Capitalization $466.24 Million USD

Valuation Analysis

Below Book Valuation: The market values Ion Beam Applications SA's assets below their book value (0.76x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Ion Beam Applications SA's assets grew by 3.1% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Ion Beam Applications SA (2000–2024)

The table below shows the annual total assets of Ion Beam Applications SA from 2000 to 2024.

Year Total Assets Change
2024-12-31 €616.10 Million
≈ $720.29 Million
+3.11%
2023-12-31 €597.53 Million
≈ $698.57 Million
-4.23%
2022-12-31 €623.90 Million
≈ $729.40 Million
+14.26%
2021-12-31 €546.05 Million
≈ $638.39 Million
+6.86%
2020-12-31 €511.00 Million
≈ $597.41 Million
+20.20%
2019-12-31 €425.11 Million
≈ $497.00 Million
+4.39%
2018-12-31 €407.24 Million
≈ $476.11 Million
+22.47%
2017-12-31 €332.52 Million
≈ $388.75 Million
-12.64%
2016-12-31 €380.62 Million
≈ $444.98 Million
-3.73%
2015-12-31 €395.35 Million
≈ $462.21 Million
+28.76%
2014-12-31 €307.06 Million
≈ $358.98 Million
+8.98%
2013-12-31 €281.75 Million
≈ $329.40 Million
-27.04%
2012-12-31 €386.20 Million
≈ $451.51 Million
-22.45%
2011-12-31 €498.01 Million
≈ $582.23 Million
-5.72%
2010-12-31 €528.21 Million
≈ $617.53 Million
+10.13%
2009-12-31 €479.64 Million
≈ $560.75 Million
-5.86%
2008-12-31 €509.52 Million
≈ $595.68 Million
+57.05%
2007-12-31 €324.44 Million
≈ $379.30 Million
+21.57%
2006-12-31 €266.87 Million
≈ $312.00 Million
+31.62%
2005-12-31 €202.75 Million
≈ $237.04 Million
-41.27%
2004-12-31 €345.22 Million
≈ $403.60 Million
-31.03%
2003-12-31 €500.56 Million
≈ $585.21 Million
-27.47%
2002-12-31 €690.15 Million
≈ $806.86 Million
-9.72%
2001-12-31 €764.48 Million
≈ $893.75 Million
+1.52%
2000-12-31 €753.05 Million
≈ $880.39 Million
--

About Ion Beam Applications SA

BR:IBAB Belgium Medical Devices
Market Cap
$549.59 Million
€470.10 Million EUR
Market Cap Rank
#12824 Global
#53 in Belgium
Share Price
€16.04
Change (1 day)
-0.99%
52-Week Range
€9.94 - €17.40
All Time High
€53.86
About

Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally. It operates through Proton Therapy and Other Accelerators; and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. Thi… Read more